MAC MACERICH CO

NYSE macerich.com


$ 17.67 $ 0.25 (1.44 %)    

Wednesday, 05-Nov-2025 15:28:52 EST
QQQ $ 625.69 $ 7.24 (1.17 %)
DIA $ 473.73 $ 2.86 (0.61 %)
SPY $ 679.91 $ 4.87 (0.72 %)
TLT $ 88.96 $ -0.54 (-0.6 %)
GLD $ 366.71 $ 0.26 (0.07 %)
$ 17.7
$ 17.39
$ 17.65 x 105
$ 17.68 x 116
$ 17.23 - $ 17.84
$ 12.24 - $ 21.63
3,080,347
na
4.53B
$ 1.27
nm
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-26-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-25-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-03-2018 06-30-2018 10-Q
31 05-07-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 11-03-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-01-2017 03-31-2017 10-Q
36 02-24-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 02-23-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 macerich-q3-ffo-035-inline-sales-253262m-beat-249473m-estimate

Macerich (NYSE:MAC) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. This is a 7.89 per...

 this-ciena-analyst-turns-bullish-here-are-top-5-upgrades-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 b-of-a-securities-upgrades-macerich-to-buy-raises-price-target-to-23

B of A Securities analyst Jeffrey Spector upgrades Macerich (NYSE: MAC) from Neutral to Buy and raises the price target from...

 evercore-isi-group-maintains-in-line-on-macerich-raises-price-target-to-20

Evercore ISI Group analyst Samir Khanal maintains Macerich (NYSE:MAC) with a In-Line and raises the price target from $18 to...

 scotiabank-maintains-sector-perform-on-macerich-raises-price-target-to-18

Scotiabank analyst Nicholas Yulico maintains Macerich (NYSE:MAC) with a Sector Perform and raises the price target from $16 ...

 jp-morgan-maintains-underweight-on-macerich-raises-price-target-to-19

JP Morgan analyst Michael Mueller maintains Macerich (NYSE:MAC) with a Underweight and raises the price target from $18 to $19.

 macerich-q2-ffo-033-misses-035-estimate-sales-249793m-beat-234110m-estimate

Macerich (NYSE:MAC) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.35 by 5.98...

 ladenburg-thalmann-initiates-coverage-on-macerich-with-buy-rating-announces-price-target-of-25

Ladenburg Thalmann analyst Destiny Hance initiates coverage on Macerich (NYSE:MAC) with a Buy rating and announces Price Tar...

 macerich-buys-raleighs-crabtree-mall-for-290m-sees-up-to-125-yield-as-part-of-growth-strategy

The Macerich Company (NYSE:MAC) (the "Company" or "Macerich"), a leading owner, operator and developer of major...

 mizuho-upgrades-macerich-to-outperform-lowers-price-target-to-18

Mizuho analyst Haendel St. Juste upgrades Macerich (NYSE:MAC) from Neutral to Outperform and lowers the price target from $2...

 truist-securities-maintains-buy-on-macerich-raises-price-target-to-21

Truist Securities analyst Ki Bin Kim maintains Macerich (NYSE:MAC) with a Buy and raises the price target from $19 to $21.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION